by The India nicotine replacement therapy market was surpassed at USD 33.13 million in 2022 and is expected to hit around USD 108.35 million by 2032, growing at a CAGR of 12.58% from 2023 to 2032.
Key Pointers
- By Product, the nicotine gums contributed the largest market share of 84% in 2022.
- By Strength, the 4 mg segment generated the maximum market share of 63% in 2022.
- By Distribution Channel, the offline segment captured the maximum market share of 69% in 2022.
The nicotine replacement therapy (NRT) market in India has witnessed substantial growth in recent years, reflecting an increased emphasis on addressing tobacco addiction. This overview aims to provide insights into the key aspects of the Indian NRT market, examining its current status, growth drivers, and the broader implications for public health.
Market Growth
The growth of the nicotine replacement therapy (NRT) market in India is propelled by several key factors. Firstly, the increasing awareness surrounding the detrimental health effects of tobacco use has stimulated a greater demand for smoking cessation solutions. Individuals are actively seeking effective methods to overcome nicotine dependency, driving the adoption of NRT products. Additionally, government-led initiatives and public health campaigns focused on tobacco control contribute significantly to market growth. The implementation of stringent regulations and policies to curb smoking, combined with efforts to educate the public about the benefits of NRT, creates a conducive environment for market expansion. Furthermore, continuous advancements in product formulations and delivery mechanisms enhance the appeal and efficacy of NRT options, attracting a broader demographic of users. As a result, the confluence of heightened awareness, supportive government measures, and ongoing product innovations collectively fuels the positive trajectory of the nicotine replacement therapy market in India.
Get a Sample: https://www.visionresearchreports.com/report/sample/41021
Report Scope of the India Nicotine Replacement Therapy Market
| Report Coverage | Details |
| Growth rate from 2023 to 2032 | CAGR of 12.58% |
| Market Size in 2022 | USD 33.13 million |
| Revenue Forecast by 2032 | USD 108.35 million |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Read More: https://www.heathcareinsights.com/infant-nutrition-market/
Market Dynamics
Drivers
- Increasing Health Awareness: A primary driver for the growth of the nicotine replacement therapy (NRT) market in India is the escalating awareness of the severe health risks associated with tobacco consumption. As individuals become more informed about the detrimental effects of smoking, there is a corresponding surge in demand for effective smoking cessation solutions like NRT.
- Government Initiatives and Regulations: Stringent governmental measures aimed at tobacco control play a pivotal role in propelling the NRT market forward. The implementation of regulatory frameworks, coupled with public health campaigns, creates a supportive environment for the adoption of NRT products. These initiatives underscore the government’s commitment to reducing tobacco-related health issues.
Restraints
- Cultural Perceptions and Stigma: A significant restraint in the India nicotine replacement therapy (NRT) market is the persistent cultural stigma associated with seeking assistance for smoking cessation. Social norms and cultural beliefs often contribute to a reluctance among individuals to openly acknowledge and address their tobacco addiction. This stigma can impede the widespread acceptance and adoption of NRT as a viable solution, hindering market growth.
- Limited Accessibility in Rural Areas: Despite the growing urbanization in India, there remains a significant rural population with limited access to healthcare facilities. The availability and awareness of nicotine replacement therapy products in rural areas are comparatively lower, posing a challenge for individuals in these regions who may be seeking smoking cessation aids. This urban-rural divide in accessibility acts as a restraint on the overall market expansion.
Opportunities
- Rising Health Consciousness: The increasing awareness of health and wellness presents a significant opportunity for the nicotine replacement therapy (NRT) market in India. As individuals become more health-conscious, there is a growing willingness to adopt smoking cessation strategies, positioning NRT as a favorable option for those looking to quit tobacco use.
- Telehealth and Digital Interventions: The rapid growth of telehealth and digital interventions offers a promising avenue for the NRT market. Digital platforms can be utilized to disseminate information, provide counseling, and deliver support programs for individuals seeking to quit smoking, thereby expanding the reach of NRT solutions.
Product Insights
Based on product, nicotine gums accounted for the largest revenue share of 84% in 2022 and are expected to grow at the fastest CAGR over the forecast period. Increasing emphasis on NRTs, growing involvement of the government, and developments in the industry are key drivers of response for the dominance. Active involvement of government in preventing the misuse of NRTs is also a major factor propelling the segment’s growth.
In 2023, to prevent the misuse of NRTs, such as nicotine gums, lozenges, and patches, the government is contemplating mandating the requirement of a prescription for the sale of all formulations containing 2 & 4 mg of nicotine. This issue was discussed by the Drugs Technical Advisory Board (DTAB), India’s leading technical advisory body on pharmaceuticals, during a meeting conducted in August 2023.
Strategic activities by emerging players are expected to offer lucrative opportunities in the review period. For instance, in May 2020, Nicotex, a smoking cessation brand under Cipla Health, joined forces with the governments of Karnataka and Goa to offer NRT to frontline workers. Such partnerships with various state health ministries enable the company to conduct these initiatives on a much larger scale and extend the company’s assistance to a broader population in their efforts to quit smoking.
Strength Insights
The 4 mg segment held the largest market share of over 63% in 2022. One of the primary drivers is the relatively higher price of 4 mg strength nicotine replacement products compared to their 2 mg counterparts. This higher pricing is often seen as indicative of increased potency for heavy smokers, which appeals to consumers seeking more robust solutions to address their nicotine cravings and addiction. Perceived effectiveness of higher nicotine concentrations and the willingness of certain consumers, such as heavy smokers, to navigate the prescription requirement in pursuit of more potent solutions to overcome nicotine addiction is another factor driving the segment growth.
2 mg nicotine replacement products are expected to witness the fastest growth over the forecast period, which can primarily be attributed to the fact that 2 mg strength products are easily available Over the Counter (OTC). Unlike the 4 mg strength nicotine replacement products, which require a prescription for purchase, the 2 mg variant can be obtained directly by consumers without doctor’s prescription. This accessibility made it a preferred choice for individuals seeking nicotine replacement therapy, improving its market penetration.
Distribution Channel Insights
The offline segment accounted for the largest revenue share of 69% in 2022. The offline distribution channel for NRT remains a critical avenue for reaching a diverse range of consumers seeking to quit smoking. Offline distribution channels allow an individual to interact directly with trained professionals. Retail pharmacies are the most preferred offline channel as these pharmacies provide a one-stop solution for smokers seeking effective cessation options. The comprehensive selection of a wide range of NRT products at retail pharmacies allows consumers to choose the most suitable NRT method.
The online distribution channel segment is expected to grow at a significant rate during the study period. The growth can be attributed to the consumer preferences, user-friendly platforms, faster shipping, and optimum prices. The online NRT market has significantly improved accessibility for individuals seeking to quit smoking. Online platforms often offer comprehensive information about various NRT options, allowing consumers to make informed decisions based on their preferences and needs. This wealth of information empowers consumers to choose the most suitable NRT product for their quit-smoking journey. These capabilities are expected to drive the segment growth.
Key Companies
- Glenmark Pharmaceuticals Ltd.
- Fertin Pharma
- Rubicon Consumer Healthcare Pvt. Ltd.
- Rusan Pharma Ltd.
- Cipla, Inc.
- Piramal Pharma Limited
- Johnson & Johnson Services, Inc.
- ITC Limited
- INVENTZ Lifesciences
- Sparsha Pharma International Pvt. Ltd.
India Nicotine Replacement Therapy Market Report Segmentations:
By Product
- Gum
- Lozenges
- Others
By Strength
- 2 mg
- 4 mg
By Distribution Channel
- Online
- Offline
- Hospital Pharmacies
- Retail Pharmacies
- Others
Buy this Premium Research Report@ https://www.visionresearchreports.com/report/checkout/41021
You can place an order or ask any questions, please feel free to contact sales@visionresearchreports.com| +1 650-460-3308
